Partnering with Clearsense, Meharry College had two main areas of focus. The first was a better understanding of the disparities surrounding Black Americans—more at risk for renal failure by using data patterns and knowledge. The second was to develop new testing and mitigation efforts to expand resources to the selected population.
Facing Health Disparities Head-On
Black Americans face a propensity of renal failure 5.5x that of the standard population
Identified population representing 14% of total population covering 87% of all renal failures
50% of the subgroup could be positively identified with only two tests
Analyzing datasets with IrisPro, the team developed a full plan to meet each goal. Leveraging the 20/20 platform, key drivers were recognized, and the Clearsense team worked in partnership to build various models based on defined objectives—including coverage and precision. Further identifying drivers and unique subgroups, Clearsense elevated the datasets with auto-segmentation allowing certain behaviors to come to the forefront—better telling a story of risk and need.
Providing insights in real-time to clinicians on the likelihood and reasons for renal failure, Clearsense not only equipped the data to identify populations most at risk but helped develop key indicators to look for in datasets in a future-forward approach. Most importantly, Clearsense was able to identify the best lab test for Chronic Kidney Disease prediction without misclassification
”Clearsense 20/20 gave our client proper computation resources and better hyperparameter tuning of XGBoost, allowing us to build a better model — one that elevated both research and patient outcomes.Charles Boicey, MS, RN-BCClearsense Co-Founder & CIO